Isaac E. Ciechanover
2018
In 2018, Isaac E. Ciechanover earned a total compensation of $6.1M as Former President & Chief Executive Officer at Atara Biotherapeutics, a 82% increase compared to previous year.
Compensation breakdown
| Bonus | $440,086 |
|---|---|
| Option Awards | $2,757,846 |
| Salary | $607,136 |
| Stock Awards | $2,327,000 |
| Other | $689 |
| Total | $6,132,757 |
Ciechanover received $2.8M in option awards, accounting for 45% of the total pay in 2018.
Ciechanover also received $440.1K in bonus, $607.1K in salary, $2.3M in stock awards and $689 in other compensation.
Rankings
In 2018, Isaac E. Ciechanover's compensation ranked 1,525th out of 14,244 executives tracked by ExecPay. In other words, Ciechanover earned more than 89.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,525 out of 14,244 | 89th |
Division Manufacturing | 534 out of 5,765 | 91st |
Major group Chemicals And Allied Products | 167 out of 2,128 | 92nd |
Industry group Drugs | 132 out of 1,817 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 31 out of 339 | 91st |
Source: SEC filing on April 22, 2020.
Ciechanover's colleagues
We found four more compensation records of executives who worked with Isaac E. Ciechanover at Atara Biotherapeutics in 2018.